Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 5, 2016

View Archived Issues

NIH begins phase I clinical testing of investigational Zika vaccine

Tribendimidine shows promise for the treatment of O. viverrini infections

University of Dundee reports compounds to treat leishmaniasis

Medshine Discovery discloses heat shock protein inhibitors

Massachusetts General Hospital and the HHS patent mRNA-targeting compounds

Katholieke Universiteit Leuven and Ortho-McNeil-Janssen Pharmaceuticals present antiviral compounds

Dana-Farber Cancer Institute and Whitehead Institute divulge dehydrogenase inhibitors

Galecto Biotech patents galectin inhibitors

Intec Pharma to develop Accordion Pill tetrahyrocannabidiol/cannabidiol

Omeros' lead MASP-3 inhibitor shows efficacy in arthritis model

DNAtrix receives grant from FDA for phase II trial in glioblastoma

Abeona Therapeutics cleared to conduct phase I/II study of gene therapy for MPS IIIA in Europe

Momenta discontinues further accrual of its phase II trial of necuparanib in pancreatic cancer

Vaxart begins phase I trial of oral norovirus tablet vaccine

Astellas reviews pipeline progress of first quarter of fiscal 2016

Shionogi updates pipeline developments of first quarter of fiscal 2016

Ono Pharmaceutical reports product and pipeline progress of first quarter of fiscal 2016

Microbion's MBN-101 earns FDA fast track designation for diabetic foot ulcer infections

AAV2 gene therapy shows promising safety and efficacy in inherited blindness

Juno Therapeutics enters into partnership with MSK and Eureka Therapeutics

ScinoPharm and CVie Therapeutics collaborate to develop new heart failure drug

Palatin Technologies gives update on bremelanotide phase III studies for HSDD

Artesunate inhibits ocular neovascularization in animal models

Griffith University and Olymvax Biopharmaceuticals to develop Group A Streptococcus vaccine

Carna Biosciences and Janssen Biotech to terminate license agreement

Rosetta Genomics launches OncoGxSelect

Quest Diagnostics launches new digital dementia assessment test for cognitive dysfunction

Bellicum Pharmaceuticals' BPX-501 and rimiducid granted orphan drug designation in Europe

Researchers initiate study to identify mutation prevalence in hereditary pancreatic cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...